ויפנד 200 מג אבקה להזרקה ישראל - עברית - Ministry of Health

ויפנד 200 מג אבקה להזרקה

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ויפנד 200 מ"ג אבקה להזרקה ישראל - עברית - Ministry of Health

ויפנד 200 מ"ג אבקה להזרקה

pfizer pharmaceuticals israel ltd - voriconazole 200 mg/vial - powder for solution for infusion - voriconazole - treatment of : - invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei), - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ויפנד 200 מג אבקה להכנת תמיסה לעירוי ישראל - עברית - Ministry of Health

ויפנד 200 מג אבקה להכנת תמיסה לעירוי

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תמיסה לאינפוזיה - voriconazole 200 mg/vial - voriconazole - voriconazole - treatment of :- invasive aspergillosis fluconazole-resistant serious invasive candida infections (including c. krusei) , - serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

ויפנד 40 מגמל אבקה להכנת תרחיף למתן דרך הפה ישראל - עברית - Ministry of Health

ויפנד 40 מגמל אבקה להכנת תרחיף למתן דרך הפה

pfizer pfe pharmaceuticals israel ltd - voriconazole - אבקה להכנת תרחיף - voriconazole 40 mg/ml - voriconazole - voriconazole - treatment of : invasive aspergillosis, fluconazole-resistant serious invasive candida infections (including c. krusei) , serious fungal infections caused by scedosporium spp. and fusarium spp.vfend should be administered primarily to immunocompromised patients with progressive possibly life-threatening infections. treatment of candidemia in non neutropenic patients.

קנסידס 50 מג ישראל - עברית - Ministry of Health

קנסידס 50 מג

merck sharp & dohme israel ltd - caspofungin as acetate - אבקה להכנת תמיסה מרוכזת לעירוי - caspofungin as acetate 50 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.

קנסידס 70 מג ישראל - עברית - Ministry of Health

קנסידס 70 מג

merck sharp & dohme israel ltd - caspofungin as acetate - אבקה להכנת תמיסה מרוכזת לעירוי - caspofungin as acetate 70 mg/vial - caspofungin - caspofungin - cancidas is indicated in adults and pediatric patients (3 months and older) for:- empirical therapy for presumed fungal infections in febrile, neutropenic patients.- treatment of candidemia and the following candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. cancidas has not been studied in endocarditis, ostemyelitis, and meningitis due to candida.- treatment of esophageal candidiasis.- treatment of invasive aspergillosis in patients who are refractory to or intolerant to other therapies (i.e. amphotericin b, lipid formulations of amphotericin b, and/or itraconazole). cancidas has not been studied as initial therapy for invasive aspergillosis.

ארקסיס 100 מג ישראל - עברית - Ministry of Health

ארקסיס 100 מג

pfizer pfe pharmaceuticals israel ltd - anidulafungin - אבקה להכנת תמיסה מרוכזת לעירוי - anidulafungin 100 mg/vial - anidulafungin - anidulafungin - eraxis is indicated for use in the treatment of the following fungal infections :candidemia and other forms of candida infections ( intra- abdominal abscess and peritonitis).

נקסבר  ישראל - עברית - Ministry of Health

נקסבר

bayer israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.

נקסבר  ישראל - עברית - Ministry of Health

נקסבר

bayer israel ltd - sorafenib as tosylate - טבליות מצופות פילם - sorafenib as tosylate 200 mg - sorafenib - sorafenib - nexavar is indicated for the treatment of patients with advanced renal cell carcinoma. treatment of patients with hepatocellular carcinoma.

ארומזין ישראל - עברית - Ministry of Health

ארומזין

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.